Health Reference Library

What's the vitamin D situation for darker-skinned UK adults?

Last reviewed 2 May 2026

This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.

Summary

UK Biobank data shows severe vitamin D deficiency in 53-57% of UK Asian and 35-39% of Black African residents versus 12-18% of White Europeans. Cutaneous synthesis is effectively absent from October to March at UK latitudes for any skin type. NHS guidance recommends year-round 10 microgram (400 IU) supplementation for African, African-Caribbean, and South Asian backgrounds, not only autumn and winter.

How it works

Cutaneous vitamin D synthesis depends on UVB radiation reaching keratinocytes in the skin. Melanin acts as a natural UVB filter: the more melanin in the epidermis, the lower the proportion of UVB photons that reach 7-dehydrocholesterol for photoconversion to previtamin D3. SACN 2016 acknowledges that efficiency of cutaneous synthesis is lower in people with darker skin and in older adults but does not commit to a single quantitative multiplier; published estimates vary across studies and depend on Fitzpatrick skin type, age, body part exposed, time of day, latitude, season, and atmospheric conditions. The practical implication for UK residents is that significantly longer sun exposure is required for darker skin to achieve equivalent synthesis. From October to late March, UK latitudes above 50 degrees north receive insufficient UVB for meaningful cutaneous synthesis in any skin type, so the year-round disadvantage operates primarily during spring and summer.

Effective dose

The 10 microgram (400 IU) daily dose is the same as for the general UK population; the difference is duration (year-round rather than autumn-winter only) reflecting the year-round risk profile. Higher therapeutic doses for documented deficiency are clinical-guidance territory; loading and maintenance protocols are covered in entry 089dd947. The NHS upper limit for ongoing supplementation is 100 microgram (4,000 IU) per day for adults, 50 microgram for children aged 1-10, and 25 microgram for infants under 12 months. Long-term exceedance can cause hypercalcaemia. Public Health England classification for serum 25-hydroxyvitamin D: deficiency below 25 nmol/L, insufficiency 25-50 nmol/L, sufficiency at or above 50 nmol/L. Unit conversion: 1 ng/mL = 2.5 nmol/L.

Forms compared

Skin pigmentation does not affect bioavailability of orally consumed vitamin D; the pigmentation issue is upstream, at cutaneous synthesis. D3 versus D2 efficacy and the cofactor combination question are addressed in dedicated entries (81cd0583 D2 vs D3; 457ce028 D3+K2+magnesium protocol; dc0ecaf2 D3 and K2 combination evidence). For darker-skinned UK residents, the practical question is supplemental dose and duration rather than form; standard 10 microgram (400 IU) D3 supplements meet NHS guidance.

Timing

Vitamin D is fat-soluble; absorption is improved when taken with dietary fat. Once-daily dosing with the largest fat-containing meal is the standard practical approach. Year-round duration is the key difference from general-population guidance: NHS recommends supplementation only from October to March for people with lighter skin, but year-round for people with African, African-Caribbean, or South Asian backgrounds. For loading regimens (intermittent higher doses for documented deficiency), see entry 089dd947.

Safety profile

Routine monitoring is not required at NHS-recommended supplemental doses. Serum 25-hydroxyvitamin D testing is appropriate where deficiency is clinically suspected (bone pain, muscle weakness, atypical fractures, malaise) or where higher therapeutic doses are being considered. Conditions requiring clinical caution before higher-dose supplementation include chronic kidney disease, hyperparathyroidism, sarcoidosis and other granulomatous diseases, and active vitamin D supplementation already at therapeutic levels. NICE pregnancy guidance covers vitamin D in pregnancy; the Healthy Start scheme provides targeted UK support.

Special populations

Pregnancy in darker-skinned UK women: vitamin D deficiency during pregnancy is associated with congenital rickets, lower birth weight, and maternal complications. NICE pregnancy guidance and the Healthy Start scheme provide targeted support. Breastfeeding: maternal supplementation supports infant stores; breastfed infants are recommended an 8.5-10 microgram daily supplement regardless of maternal status. Children with darker skin: NHS recommends 10 microgram year-round from age 1-4 onwards, with continued attention through childhood. Older adults with darker skin: age-related reduction in cutaneous synthesis efficiency adds further compounding to melanin filtering. Beyond melanin, several factors further compound the deficiency risk: cultural dress practices that cover skin, lower dietary vitamin D intake (Bangladeshi median 3.0 microgram per day, Indian 1.0, Pakistani 1.5 per UK Biobank analysis), higher BMI (vitamin D sequestered in adipose tissue), northern UK geographic location, and socioeconomic deprivation.

Interactions

There is no published evidence that the magnesium and vitamin D activation pathway functions differently in different ethnic groups. The elevated deficiency rates in UK darker-skinned populations are driven primarily by cutaneous synthesis differences and dietary intake patterns, not by activation differences. Combined D3 plus K2 plus magnesium protocols are covered in entry 457ce028. Vitamin D interactions with medications (corticosteroids, anticonvulsants, weight-loss agents, cholestyramine, mineral oil) are addressed in dedicated entries; these interactions affect all populations and are not specific to skin colour.

Guideline positions

Public Health England classifies serum 25-hydroxyvitamin D below 25 nmol/L as deficient. SACN 2016 includes dark-skinned ethnic groups in the year-round at-risk category for serum levels below this threshold and identifies efficiency of cutaneous synthesis as lower in darker skin without committing to a quantitative multiplier. NICE pregnancy guidance covers vitamin D screening and supplementation in pregnancy. The NIH Office of Dietary Supplements provides international reference for RDA, UL, threshold framework, and population risk groups including those with darker skin.

Practical framework

Standard practical sequence: (1) confirm year-round supplementation is in place at the 10 microgram (400 IU) dose; (2) take with the largest fat-containing meal of the day; (3) consider blood testing if symptomatic or where higher doses are being contemplated; (4) for documented deficiency at 25-hydroxyvitamin D below 25 nmol/L, clinical-guidance loading and maintenance protocols apply (entry 089dd947). Population-level guidance is calibrated to average risk; individual circumstances such as high summer sun exposure, lower BMI, or higher dietary intake may modify the picture, and blood testing under clinical guidance gives a more accurate read where these factors diverge from typical. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Within the broad categories of darker skin or Asian or Black ancestry there is substantial individual variation. Darker-skinned individuals with high summer sun exposure, lower BMI, and adequate dietary vitamin D may achieve sufficiency without supplementation. Lighter-skinned individuals with very low sun exposure, higher BMI, or restrictive diets may be deficient despite favourable melanin status. The mechanistic basis (melanin filtering UVB) is undisputed; the precise quantitative multiplier between Fitzpatrick skin types is variable across published studies and is not a clinically actionable number. UK Biobank covers age 40-69 at recruitment, so the prevalence data does not directly speak to children or the very elderly; the Patel 2013 Birmingham study covers a different age range and primary care population, providing useful corroboration.

Who this matters for

This entry is relevant for the following groups, conditions, and medication contexts:

Sources

  1. NHS UK. Vitamin D. NHS UK (UK government).
  2. Scientific Advisory Committee on Nutrition (UK government) 2016. SACN Vitamin D and Health report. Scientific Advisory Committee on Nutrition (SACN, UK government).
  3. Sutherland JP, Zhou A, Leach MJ, Hyppönen E 2021. Differences and determinants of vitamin D deficiency among UK biobank participants: A cross-ethnic and socioeconomic study. Clinical Nutrition. PMID: 33309415 · DOI: 10.1016/j.clnu.2020.11.019
  4. Lin LY, Smeeth L, Langan S, Warren-Gash C 2021. Distribution of vitamin D status in the UK: a cross-sectional analysis of UK Biobank. BMJ Open. PMID: 33408196 · DOI: 10.1136/bmjopen-2020-038503
  5. Patel JV et al 2013. Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study. International Journal of Cardiology. PMID: 23140614 · DOI: 10.1016/j.ijcard.2012.05.081
  6. NIH Office of Dietary Supplements. NIH Office of Dietary Supplements — Vitamin D Fact Sheet for Health Professionals. NIH Office of Dietary Supplements (US government).

Related entries

Back to Vitamin D overview